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I . BACKGROUND AND AIMS 
1.1 Importance of tissue resistance in altered lung mechanics 
The two major compartments contributing to the lung function are the conductive airways and 
the lung parenchyma. The airway mechanics can be characterized by a flow resistance (Raw), 
while the lung tissue is described by viscoelastic elements including a parameter related to the 
dissipative properties of the parenchyma (Rti) and the lung tissue elasticity. Although the 
routine procedures performed during the induction and maintenance of general anaesthesia 
may also alter both the airway and the parenchymal properties, there is a lack of information 
in the literature about the differential behaviour of the airway and tissue compartments. An 
understanding of the underlying mechanisms allows a better targeting of the treatment to the 
compartment primarily involved in the compromised lungs. 
. 1.2. Volatile anaesthetic agents 
Halothane and isoflurane have been used for many years for the induction and maintenance 
of anaesthesia. However, their high metabolism rate, and the high liver toxicity and negative 
cardiac inotropic action of halothane led to demand for the development of novel molecules 
with fewer side-effects. Thus, over the last decade, two new major inhalation agents have 
been introduced in anaesthesia and are now widely used in clinical practice: sevoflurane and 
desflurane. Both drags have a number of advantages that make their use for anaesthesia 
attractive. Nevertheless, there is still a lack of knowledge as to whether these new volatile 
agents display comparable protective effects against airway constriction with that of 
halothane or isoflurane. Furthermore, separation of airway and tissue mechanics provides 
anesthesiologists, who are primarily concerned with changes in airway mechanics, with a 
better description of the changes in the lungs. 
1.3. Effects of endogenous histamine release 
Among the mediators, released following an anaphylactoid or anaphylactic reaction, 
histamine is most commonly released following the administration of anaesthetic agents. 
Although the effects of exogenous histamine on the mechanical properties of the respiratory 
system have been well established, the consequences of the endogenous liberation of 
histamine on the lung mechanics have not been investigated. 
1.4. Interaction between pulmonary haemodynamics and lung mechanics 
Changes in pulmonary haemodynamic conditions have been shown to alter the mechanical 
properties of the lungs. A compromised lung function has been observed in clinical situations 
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involving an abnormally high pulmonary blood flow (Qp) and/or an elevated pulmonary 
arterial pressure (Ppa). Nevertheless, the results of these previous studies lead to inconsistent 
conclusions as to which of the pulmonary haemodynamic parameters has the dominant effect 
on the lung mechanics. In clinical practice, it is possible to influence the pulmonary 
haemodynamic parameters relatively selectively by pharmacological means; hence, it is 
important to clarify the mechanism responsible for the adverse changes in the lung mechanics. * • • 1 
1.5. Aims 
The primary aim of the present thesis is a better understanding of the behaviour of the 
respiratory system through study of the separate airway and tissue mechanical responses 
occurring in routine anaesthetic practice. The specific aims of the present thesis were: 
• To estimate the protective effects of common volatile anaesthetic agents against constriction 
in the airway and lung tissue compartments in order to establish the optimum choice of the 
volatile agent in situations with a high risk of enhanced airway reactivity. 
• To investigate the effects of histamine-releasing anaesthetic drugs on the airway and 
parenchymal mechanics separately; and to compare the results with those obtained by the 
direct administration of histamine. 
• To characterize the respective roles of the pulmonary capillary pressure and blood flow in 
the altered airway and parenchymal mechanics following acute changes in the pulmonary 
haemodynamics. 
2. MATERIALS AND METHODS 
The animal model in each protocol was chosen in accordance with the ability to manipulate 
the experimental conditions and to measure the lung mechanics. 
2.1. Animal models and experimental protocols 
2.1.1. Three groups of anaesthetized, paralyzed, mechanically ventilated open-chest piglets 
were to compare the ability of halotahne and isoflurane to prevent parenchymal constriction. 
In the piglets in the control group, anaesthesia was induced with pentobarbital. The piglets in 
the other groups received inhalation induction with either sevoflurane or halothane. 
Anaesthesia was maintained with the corresponding agent at 1 minimum alveolar 
concentration (MAC). After measurement of the baseline lung mechanics, the piglets received 
a continuous infusion of methacholine (Mch) and the lung mechanics was measured each 
2 min until a stable response was attained (at least 10 min). The Mch infusion was then 
stopped and the lung was allowed to return to the baseline. The Mch infusion was 
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subsequently recommenced and the response measured again, as described above. This 
procedure was repeated twice, after which the concentration of the volatile agent was 
increased to 1.3 MAC and further data were collected. 
2.1.2. Protective effects of volatile agents against broncho-constriction induced by Mch were 
studied in five groups of open-chest rats. Following baseline lung mechanical measurements, 
the iv infusion of Mch was started at a rate of 32 pg/kg/min. Lung mechanics was then 
recorded at 1-min intervals until the establishment of a stable level of constriction. After 
completion of the first Mch challenge, the rats were randomly assigned to the five protocol 
groups. In the control group, the same dose of Mch was infused twice to test the 
reproducibility of the responses, while pentobarbital was injected iv to maintain anaesthesia. 
The anaesthesia was maintained in the other groups with halothane, isoflurane, sevofiurane or 
desflurane. When the 1 MAC end-tidal concentration of the volatile agent was achieved and 
stable haemodynamic conditions had been established, lung mechanical measurements were 
performed to obtain new baseline and the Mch challenge was repeated at the same 
concentration. Finally, the volatile agent concentration was increased to 2 MAC and data 
were collected again before and during Mch infusion. 
2.1.3. To investigate the effects of endogen histamine on the airway and parenchymal 
mechanics, open-chest rabbits were randomly assigned to one of the following two protocol 
groups. No pretreatment was performed in one group of rabbits, while the animals in the other 
group received clemastine and ranitidine, HI and H2 receptor blockers, respectively. 
Following baseline lung mechanical measurements, an iv bolus of mivacurium was 
administered. Lung mechanics was measured in 1-min intervals until 10 min. Another set of 
lung mechanical measurement was made 30 minutes later, and an iv bolus of histamine was 
then injected. Arterial and venous blood samples were taken 1, 3 and 6 min following 
mivacurium administration, and histamine concentrations were obtained by enzyme 
immunoassay. 
2.1.4. Isolated perfused rat lungs offer ideal conditions for independent manipulation of 
pulmonry haemodynamical parameters. Following the establishment of a steady-state 
conditions, the lungs were randomly assigned to one of the following three groups: 
In one group of lungs, the perfusion of the lungs was established by applying normal 
levels of Ppa (17.S mmHg) and left atrial pressure (Pla = 7.3 mmHg). The resulting flow 
(3-6 ml/min) was then kept constant for each lung during the experiments, while the estimated 
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mean pulmonary capillary pressure (PCEST) was altered from 5 mmHg to 25 mmHg in steps of 
5 mmHg (group P). In the next group of lungs, Qp was doubled stepwise from 2.5 ml/min to 
15 ml/min, while the mean P C E S T was kept at an approximately physiological value of 
10 mmHg (group FL). Finally, Qp was altered while P C E S T was kept high (group FH). In these 
lungs, a P C E S T of 20 mmHg was set after the perfusion had reached the steady state, and Qp 
was decreased from 30 ml/min in 5-ml/min steps until a Qp of 5 ml/min was achieved, and it 
was then decreased to 2.5 ml/min. This was accomplished by decreasing and increasing the 
heights of the perfusion reservoir and the outflow of the left ventricular catheter, respectively. 
2.2. Measurement of airway and tissue mechanics 
2.2.1. Alveolar capsule technique in piglets. After chest opening via a mid-line sternotomy, 
small plastic capsules were glued to the pleural surface. To measure the alveolar pressure 
(PA), the underlying pleura was punctured with a needle. Pulmonary resistance (RL) and 
compliance (CL), Raw and Rti were calculated from measurements of P A , airway opening 
pressure, central airflow and volume, recorded during mechanical ventilation, by using a 
multi-linear regression implementation of the equation of motion of the lungs. 
2.2.2. Forced oscillation techniques. To measure the lung input impedance (ZL), the setup 
was adjusted to the size of the animal. The wavetube technique was used to measure ZL in 
rats. This technique was specially designed to measure the forced oscillatory input impedance 
of small animals without a need to estimate the oscillatory flow. 
The measurement system for collection of ZL in rabbits contained a screen 
pneumotachograph and a pressure transducer connected via a side-port of the endotracheal 
tube to measure the tracheal pressure during oscillations. 
2.2.3. Separation of airway and parenchymal parameters. To separate the mechanical 
properties of the airways and the parenchyma, the distinct difference in the frequency 
dependences of the two compartments at low oscillation frequencies was utilized. The airway 
and parenchymal properties were separated by fitting a model incorporating an airway 
compartment containing Raw and inertance (law), in series with a constant-phase tissue 
model including damping (G) and elastance (H), to the ZL spectra by minimizing the 
differences between the measured and modelled impedance values: 
ZL= Raw + jcolaw + (G-jH)/coa 
where j is the imaginary unit, to is the angular frequency (2nf), and a=(2/7t)arctan(H/G). 
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3. RESULTS 
3.1. Prevention of Mch-induced changes in parenchymal mechanics in piglets by 
halothane and sevoflurane 
Both sevoflurane and halothane markedly attenuated the Mch-induced increase in the RL. The 
mean percentage changes in RL after Mch in the sevoflurane (36±6[SE]%) and halothane 
(38±20%) groups were significantly less than in the control group (100±58%). The increase in 
Rti was also significantly less in both the sevoflurane (111±16%) and halothane (105±47%) 
groups as compared with the control group (283±158%). The decrease in CL was likewise 
significantly less when the Mch infusion was commenced in the presence of sevoflurane 
(28%) or halothane (29%) than in the control group (49%). After the increase of halothane 
and sevoflurane to 1.3 MAC, we observed a further attenuation of RL and Rti, respectively, 
with no significant difference in either group (-10.8% and -6.8% for RL, p=0.12; -20 % and 
-17% for Rti, p=0.37). 
3.2. Effects of common volatile anaesthetic agents on Mch-induced bronchoconstriction 
in rats 
Mch induced marked increases in Raw and G, essentially no change in law, and slight 
increases in H. Mch generated a markedly lower airway constriction when the anaesthesia 
was maintained with the volatile agents. Increase of the concentration of the volatile agents to 
2 MAC tended to enhance their protective effects, although this dose dependence was not 
statistically significant. The comparisons of the groups revealed no statistically significant 
difference between the volatile agents as concerns the ability to protect against Mch-induced 
airway constriction. 
The increases in the parenchymal parameters during Mch infusion were always far 
lower than those in Raw. No statistically significant difference in the elevation of G was 
found between the Mch challenges in the control group, whereas all the volatile agents 
decreased the elevations in G significantly (p<0.05). There was no difference between the 
volatile agents in moderating the increases in G. The elevation of the concentration of 
sevoflurane or desflurane from 1 to 2 MAC tended to intensify their protective effects, 
whereas such dose-dependent effects were not obvious with halothane and isoflurane. The 
slight, though statistically significant increases in H were not affected by administration of the 
volatile agents. 
10 
3.3. Endogenous histamine release in rabbits 
There was a significant increase in venous plasma histamine level at 1, 3 and 6 min following 
mivacurium injection. The plasma histamine levels of the control rabbits and those after 
antihistamine pre treatment were comparable. 
Significant increases in Raw and G were observed following either mivacurium or 
histamine administration. The increase in Raw induced by either mivacurium (28.7±2.3%) or 
histamine (70.6±12.6%) was markedly and statistically significantly reduced by antihistamine 
pretreatment (6.6±3.4% and 3.6±3.7%, respectively). The relatively small mivacurium-
induced increases in G (23.9±6.9%) and H (7.6±4.4%) were not inhibited significantly by 
antihistamine pretreatment (15.5±3.0% and 3.6±2.1%); in contrast, the increases in these 
parameters in response to histamine (21.0±4.9 and 15.6±4.5%) were significantly smaller in 
the rabbits that received histamine receptor blockers (0.3±2.6% and 6.3±1.0%). 
3.4. Effects of altered pulmonary vascular pressure or flow on the mechanics of isolated 
rat lungs 
In the lungs of the group P, increasing P C E S T caused gradual increases in Raw, which reached 
statistically significant levels above IS mmHg. No systematic change in law was observed in 
response to changes in P C E S T - G and H responded to the altered P C E S T with similar patterns of 
change: they were minimal at a P C E S T level of 10 mmHg and exhibited statistically significant 
increases at both lower (20.9±4.5% for G and 17.1±4.2% for H at 5 mmHg) and higher P C E S T 
values (26.9+3.4% and 26.7±5.5%, respectively, at 20 mmHg). 
In the group FL, no statistically significant changes occurred in the airway parameters; 
the maximal relative changes in Raw and law were 32.3±15.1% and -30.5±11.S%, 
respectively. Increasing Qp caused gradual increases in the parenchymal parameters; the 
changes became statistically significant at 10 ml/min for G and 12.3 ml/min for H. The 
maximal relative changes were 35.8±4.1% and 19.4±4.1% for G and H, respectively. 
In the group FH, monotonous and statistically significant elevations in Raw were 
obtained with decreasing Qp, with a maximal relative change of 48.3±13.5% before oedema 
development. No systematic changes were observed in law with changing Qp. G and H 
exhibited monotonous increases with decreasing Qp; significant changes were observed in 
both parameters from 15 ml/min, and the maximum elevations before oedema development 
were 29.2±7.8% and 28.2±6.4% for G and H, respectively. 
Pooling of the data points obtained in the three groups did not reveal any clear 
relationship between Ppa the lung mechanical parameters. No clear effects of Pla on Raw 
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were evident at low Pla levels; however, systematically higher Raw values were observed at 
higher Pla. G and H were minimum at Pla levels of around 7-10 mmHg, whereas these 
parameters were markedly higher at both lower and higher Pla. 
« 4. DISCUSSION 
4.1. Prevention of parenchymal constriction by halothane and sevoflurane 
Our study on piglets revealed that 
i) intravenous administration of Mch essentially induced increases in the lung tissue 
parameters, but with no significant effect on Raw, 
ii) sevoflurane was as effective as halothane in preventing lung constriction. 
The lack of action of Mch on the Raw in piglets was a somewhat surprising finding, since 
Mch, a non-specific muscarinic receptor agonist, may have been expected to increase both 
Raw and Rti, as has been demonstrated in other species. The lack of increase in Raw in our 
piglets may be attributed to the 
- the immaturity of the muscarinic receptor function, which has been described in piglets 
less than 1 week old, and/or 
- the modest dose applied in the present study, since a difference in the relative sensitivities 
of the airways and the parenchyma to Mch has also been reported in puppies, and/or 
- the use of the local alveolar pressure to separate the airway and parenchymal properties in 
the presence of a ventilation inhomogeneity during the Mch challenge 
Our finding that sevoflurane and halothane appear to have similar effects on Rti is 
compatible with previous reports demonstrating an effect of halothane on the parenchymal 
mechanics in canine lungs. 
In this animal model, however, we failed to demonstrate an effect of Mch on the airways, 
and thus we were unable to compare the preventive effect of sevoflurane with that of 
halothane against Mch-induced bronchoconstriction. Accordingly, we designed a new study, 
involving another animal model in which Mch has been demonstrated to induce airway 
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constriction. Moreover, in order to avoid the effects of airway constriction on the tissue 
inhomogeneities and hence on the alveolar pressure sampling, for further studies we used a « well-validated method, the low-frequency forced oscillation technique, to measure ZL. 
4.2. Prevention of airway constriction by volatile agents 
In this study, we demonstrate that isoflurane, sevoflurane and desflurane are as effective as 
halothane in protecting against Mch-induced airway constriction in rats. 
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4.2.1. Interpretation of the Mch-induced lung response. Marked elevation in Raw was 
associated with a parallel increase in G and no change in H. This pattern indicate that Mch 
induced a marked and highly heterogeneous airway constriction, whereas the increases in G 
were primarily due to enhanced ventilation inhomogeneities. 
4.2.2. Protective effects of volatile agents. All volatile agents exerted comparable protective 
effects against Mch-induced airway constriction. They also counteracted the development of 
ventilation inhomogeneities during the Mch challenge, as evidenced by the lower increases in 
G. This suggests that 
- all volatile agents involved in the present study act preferentially on the small peripheral 
airways, where the heterogeneities originate, and 
- there is no difference between the volatile agents in this regard 
It is difficult to compare these findings with the results of previous investigations, since the 
latter used global measures to characterize the mechanical status of the lungs, and the 
protective effects of volatile gases against the airway and parenchymal responses were not 
estimated separately. 
4.2.3. Effects of volatile agent concentration. Increase of the concentration to 2 MAC did not 
result in any significant additional protective effect for any of the anaesthetic gases. This 
finding is in agreement with previous studies indicating no dose dependence when 
concentrations greater than 1 MAC were used. 
4.3. Counteracting the bronchospasm induced by endogenous histamine release in 
rabbits 
4.3.1. Site of histamine release. A significant elevation in plasma histamine level following 
mivacurium administration was observed only in the central venous blood, whereas the 
arterial blood leaving the pulmonary capillaries was essentially free from endogenous 
histamine. Therefore, the endogenous histamine appears to be at least partly systemic in 
origin. 
4.3.2. Effects of endogenous and exogenous histamine. Both endogenous and exogenous 
histamine induced significant airway nanowings and elevations in the parenchymal 
mechanical parameters. Ventilation heterogeneities were likely to contribute to the increases 
in G following either mivacurium or histamine administrations; however, the contribution of 
this phenomenon depends on the agent administered. 
Following mivacurium administrations, the changes in G do not always follow those 
in Raw. For instance, significant elevations in G were still observed even during mild airway 
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constrictions in the animals pretieated with antihistamine, suggesting that a real parenchymal 
response to mivacurium may also have occurred. 
4.3.3. Preventive effects of antihistamines. Pretreatment with clemastine and ranitidine, 
commonly used in clinical practice, were employed in the present study in order to ensure 
complete saturation of the histamine receptors. This pretreatment 
- exerted a protective effect against the lung constriction induced by exogenous histamine, 
- completely abolished the increases in the airway and parenchymal parameters following 
the histamine challenge. 
Despite this protection, statistically significant responses in Raw and G remained following 
mivacurium administration suggesting that mivacurium may have liberated mediators other 
than histamine that selectively affect the parenchymal properties. 
4.4. Interactions between pulmonary haemodynamics and lung function 
The blood flow and pressure in the pulmonary circulation were varied independently in 
isolated rat lungs, and the resulting changes in the airway and parenchymal mechanics were 
systematically investigated. 
4.4.1. Effects of pulmonary capillary pressure on lung mechanics. Increase of P C E S T from 3 to 
23 mmHg had significant effects on the mechanical properties of the lung. The deterioration 
of lung mechanics at high P C E S T can be attributed to the parallel elevations in Ppa and Pla, 
which may increase the tension of the walls of the pulmonary capillaries in the alveoli. The 
decreases in total lung capacity at high vascular pressures may also have contributed 
The mechanism for the elevated parenchymal parameters at low pulmonary capillary pressure 
levels is not completely clear. It can be expected that a low pressure in the pulmonary 
capillaries results in a decreased tension of the pulmonary capillary walls, which may lead to 
an unstable geometrical structure of the alveolar space. 
4.4.2. Pulmonary blood flow and lung mechanics. Significant but opposite changes were 
obtained in the lung mechanics with changing Qp at normal and at high P C E S T levels. Through 
a combination of the results from all the protocol groups the underlying mechanism may be 
explained. 
4.4.3. Altered pulmonary arterial pressure and lung mechanics. Although changes in P C E S T or 
Qp altered the lung mechanics consistently, the combination of the results from these protocol 
groups revealed no coherent relationship between Ppa and the mechanical parameters of the 
lung. Consequently, our data suggest that Ppa is not the primary variable that determines the 
10 
mechanical properties of the airways or the parenchyma following acute changes in the 
pulmonary haemodynamics. 
4.4.4. Relationship between left atrial pressure and lung mechanics. There are consistent 
relationships between the postcapillary pressure and the mechanical conditions of the airways 
and the parenchyma. These relationships demonstrate that a low pulmonary venous pressure 
does not have an adverse effect on the airway mechanics, although it causes increases in both 
G and H. At high Pla levels, the decreases in the overall airway diameter are associated with 
an impairment in parenchymal viscoelastic properties. 
5. IMPLICATIONS 
- Sevoflurane can be used with confidence to replace halothane in the induction and 
maintainance of anaesthesia, since it protects against both airway and parenchymal 
constrictions. 
- The use of inhalation agents is preferable to intravenous administration in patients where 
cholinergic stimulation may occur during anaesthesia management. 
- The use of antihistamine drugs as part of the anaesthetic premedication is mandatory in 
atopic patients at high risk of an anaphylactoid reaction. 
- Maintenance of the left atrial pressure within the physiological range during anaesthetic 
management may avoid deterioration of the viscoelastic properties of the lung 
parenchyma. 
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